NCT03325387View on ClinicalTrials.gov

A Study of Multiple Doses of LY3305677 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

October 27, 2017

Primary Completion Date

August 3, 2018

Study Completion Date

August 3, 2018

Conditions
Healthy
Interventions
DRUG

LY3305677

Administered SC

DRUG

Placebo

Administered SC

Trial Locations (1)

LS2 9LH

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician., Leeds

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03325387 - A Study of Multiple Doses of LY3305677 in Healthy Participants | Biotech Hunter | Biotech Hunter